Diasome Pharmaceuticals to Present HDV-Insulin Phase 2b Clinical Data at EASD 2026 and Inaugural Breakthrough T1D Clinical & Research Congress
Latest Updates

CareTalk Podcast: "Targeting the Root Causes of Metabolic Disease w/ Bob Geho, Founder & CEO, Diasome”

Latest Updates

News

Ira Pastor, host of Progress, Potential and Possibilities, interviews Robert Geho

Read More

Diasome’s HDV-Insulin for T1D Finalizing Phase III Plans After Promising Data

Read More

Diasome Pharmaceuticals to Present HDV-Insulin Phase 2b Clinical Data at EASD 2026 and Inaugural Breakthrough T1D Clinical & Research Congress

Read More

Diasome Pharmaceuticals Strengthens Leadership Team as Company Prepares for Phase 3 Development

Read More
View All